Physician profile
Jeffrie Kindred
NPI 1033316484
$5,689.25
in general payments reported to CMS, 2019-2025
47 companies · $1,267 in 2025
The $1,267 reported for 2025 was more than what 91% of Sports Medicine (Family Medicine) providers received nationally (typical 2025 total: $113).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $640 · 2020: $701 · 2021: $760 · 2022: $1,155 · 2023: $593 · 2024: $572 · 2025: $1,267.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,432.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,431.74 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $1,519.49 | 2019-2025 | Ozempic, Rybelsus, Wegovy |
| Lilly USA, LLC | $734.04 | 2019-2025 | Mounjaro, Jardiance, Zepbound |
| Pfizer INC. | $493.52 | 2019-2025 | |
| Astrazeneca Pharmaceuticals LP | $268.42 | 2020-2025 | Farxiga, Flumist Quadrivalent |
| Sanofi-Aventis U.S. LLC | $227.56 | 2019-2022 | |
| Amgen INC. | $177.44 | 2019-2025 | Krystexxa, Evenity, Prolia |
| Astellas Pharma US INC | $171.41 | 2019-2021 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $133.48 | 2020-2024 | Xifaxan |
| Exact Sciences Corporation | $127.01 | 2023-2025 | Cologuard Collection Kit |
| Jazz Pharmaceuticals INC. | $123.00 | 2022 | |
| Eisai INC. | $111.67 | 2020-2021 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $107.11 | 2019-2021 | |
| Phathom Pharmaceuticals, INC. | $105.10 | 2024-2025 | Voquezna |
| Biohaven Pharmaceutical Holding Company LTD. | $100.20 | 2022 | |
| Merck Sharp & Dohme LLC | $94.60 | 2020-2022 |
Show all 47 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jeffrie Kindred listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.